CVE-2014-5401
CVE-2014-5401 is a critical-severity vulnerability in Hospira Mednet with a CVSS 3.x base score of 9.8. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-94.
Key facts
- Severity: Critical (CVSS 3.x base score 9.8)
- CVSS v2: 10.0
- EPSS exploit prediction: 5% (91st percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-94
- Affected product: Hospira Mednet
- Published:
- Last modified:
Description
Hospira MedNet software version 5.8 and prior uses vulnerable versions of the JBoss Enterprise Application Platform software that may allow unauthenticated users to execute arbitrary code on the target system. Hospira has developed a new version of the MedNet software, MedNet 6.1. Existing versions of MedNet can be upgraded to MedNet 6.1.
Frequently asked questions
- What is CVE-2014-5401?
- Hospira MedNet software version 5.8 and prior uses vulnerable versions of the JBoss Enterprise Application Platform software that may allow unauthenticated users to execute arbitrary code on the target system. Hospira has developed a new version of the MedNet software, MedNet 6.1. Existing versions of MedNet can be upgraded to MedNet 6.1.
- How severe is CVE-2014-5401?
- CVE-2014-5401 has a CVSS 3.x base score of 9.8, rated critical severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity high, and availability high.
- Is CVE-2014-5401 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 5% (91st percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2014-5401?
- CVE-2014-5401 affects Hospira Mednet. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2014-5401?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its critical severity, prioritise patching exposed systems.
- When was CVE-2014-5401 published?
- CVE-2014-5401 was published on 2019-03-26 and last updated on 2026-06-17.
References
- https://github.com/cisagov/CSAF/blob/develop/csaf_files/OT/white/2015/icsa-15-090-03.json
- https://www.cisa.gov/news-events/ics-advisories/icsa-15-090-03
- https://ics-cert.us-cert.gov/advisories/ICSA-15-090-03
Affected products (1)
- cpe:2.3:a:hospira:mednet:*:*:*:*:*:*:*:*
More vulnerabilities in Hospira Mednet
- CVE-2014-5405 — Critical (CVSS 9.0): Hospira MedNet before 6.1 uses a hardcoded cleartext password to control SQL database authorization, which allows…
- CVE-2014-5403 — Medium (CVSS 6.8): Hospira MedNet before 6.1 uses hardcoded cryptographic keys for protection of data transmission from infusion pumps,…
- CVE-2014-5400 — Medium (CVSS 6.8): The installation component in Hospira MedNet before 6.1 places cleartext credentials in configuration files, which…
All CVEs affecting Hospira Mednet →
Other CWE-94 (Code Injection) vulnerabilities
- CVE-2026-57624 — Critical (CVSS 10.0): Unauthenticated Remote Code Execution (RCE) in Blocksy Companion Pro <= 2.1.46 versions.
- CVE-2026-10134 — Critical (CVSS 10.0): IBM Langflow OSS 1.0.0 through 1.9.3 allows an attacker to read every secret available to the Langflow process, read…
- CVE-2026-53576 — Critical (CVSS 10.0): Kestra is an open-source, event-driven orchestration platform. Prior to 1.0.45 and 1.3.21, the authentication filter…
- CVE-2026-10561 — Critical (CVSS 10.0): IBM Langflow OSS 1.0.0 through 1.9.3 has an vulnerability due to an improper isolation of Python execution combined…
- CVE-2026-25470 — Critical (CVSS 10.0): Improper Control of Generation of Code ('Code Injection') vulnerability in ACPT ACPT (Pro) - Custom Post Types Plugin…
- CVE-2026-48836 — Critical (CVSS 10.0): Unauthenticated Remote Code Execution (RCE) in Easy Invoice <= 2.1.19 versions.